Patents by Inventor Kenneth Pienta

Kenneth Pienta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
    Publication number: 20210138082
    Abstract: The present invention features methods of directly targeting specific cell surface receptors on the M2 macrophage for antibody or nanoparticle directed therapy.
    Type: Application
    Filed: August 24, 2020
    Publication date: May 13, 2021
    Inventor: Kenneth Pienta
  • TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
    Publication number: 20180264130
    Abstract: The present invention features methods of directly targeting specific cell surface receptors on the M2 macrophage for antibody or nanoparticle directed therapy.
    Type: Application
    Filed: November 30, 2017
    Publication date: September 20, 2018
    Inventor: Kenneth Pienta
  • TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
    Publication number: 20160220692
    Abstract: The present invention features methods of directly targeting specific cell surface receptors on the M2 macrophage for antibody or nanoparticle directed therapy.
    Type: Application
    Filed: September 9, 2014
    Publication date: August 4, 2016
    Inventor: Kenneth PIENTA
  • Systems and methods for tissue imaging
    Patent number: 8185186
    Abstract: The present invention provides systems and methods for monitoring tissue regions. In particular, the present invention provides systems and methods for detecting changes in tissue regions over a period of time. In some embodiments, the systems and methods of the present invention are used to evaluate the effectiveness of a particular treatment of a tissue region. In some embodiments, the systems and methods employ functional diffusion map algorithms for imaging changes in tissue regions over time and/or in response to therapeutic interventions.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: May 22, 2012
    Assignee: The Regents of the University of Michigan
    Inventors: Brian D. Ross, Alnawaz Rehemtulla, Thomas L. Chenevert, Charles R. Meyer, Kuei C. Lee, Kenneth Pienta, Maha Hussein, Anne Schott
  • COMPOSITIONS AND METHODS FOR ASSESSING DISORDERS
    Publication number: 20090136945
    Abstract: The present invention relates to compositions and methods for disorder (e.g., hyperproliferative disorders, inflammatory disorders) research, diagnosis, and treatment, including but not limited to, bio-markers specific for a particular disorder (e.g., cancer, systemic lupus erythematosus). In particular, the present invention relates to peripheral blood mononuclear cells (PBMCs) as bio-markers specific for particular disorders.
    Type: Application
    Filed: October 10, 2008
    Publication date: May 28, 2009
    Applicant: The Regents of the University of Michigan
    Inventors: Robert D. Loberg, Kenneth Pienta
  • SYSTEMS AND METHODS FOR TISSUE IMAGING
    Publication number: 20090035218
    Abstract: The present invention provides systems and methods for monitoring tissue regions. In particular, the present invention provides systems and methods for detecting changes in tissue regions over a period of time. In some embodiments, the systems and methods of the present invention are used to evaluate the effectiveness of a particular treatment of a tissue region. In some embodiments, the systems and methods employ functional diffusion map algorithms for imaging changes in tissue regions over time and/or in response to therapeutic interventions.
    Type: Application
    Filed: April 11, 2008
    Publication date: February 5, 2009
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Brian D. Ross, Alnawaz Rehemtulla, Thomas L. Chenevert, Charles R. Meyer, Kuei C. Lee, Kenneth Pienta, Maha Hussein, Anne Schott
  • Diagnosis and treatment O prostate cancer
    Publication number: 20080118437
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, treatment and research, including but not limited to, cancer markers and uses of cancer markers. In particular, the present invention provides compositions and methods for targeting MCP-1 in prostate cancer.
    Type: Application
    Filed: March 1, 2007
    Publication date: May 22, 2008
    Applicant: Regents of the University of Michigan
    Inventors: Kenneth Pienta, Robert D. Loberg
  • Compositions and methods for detecting and treating cancer
    Publication number: 20070104717
    Abstract: The present invention relates to compositions and methods for cancer diagnostics and treatment, including but not limited to, CD55 and/or CD97 cancer markers. In particular, the present invention provides compositions and methods of using CD55 and/or CD97 in the diagnosis and treatment of prostate cancers.
    Type: Application
    Filed: September 12, 2006
    Publication date: May 10, 2007
    Applicant: Regents of the University of Michigan
    Inventors: Kenneth Pienta, Robert Loberg